US Anesthesia drugs Market Outlook to 2028

Market Overview:

US Anesthesia Drug Market is concerned with the development of anesthesia drugs which are primarily used in surgeries to numb the pain. Every year, almost 6 million surgical cases are performed in the US which results in the increasing demand for anesthesia drugs.

According to the report, the US Anesthesia Drug market is anticipated to grow at a CAGR of ~4% in the next five years owing to rise in surgical cases, geriatric population, chronic pain and technological advancements.

The United States Anesthesia Drug market is significantly growing to various reasons such as rise in surgical procedures, rise in geriatric population, technological advancements and rise in cases of chronic pain. There has been a significant rise in surgical procedures done in the US over the years. Increase in ageing population results in increase in surgical procedures which ultimately rises the demand for anesthesia drugs. In the past 5 decades, the ageing population has gone from ~25,000 per 100,000 people in 1980s to ~54,000 per 100,000 people in 2020s. Technological advancements also play a greater role in the growth of US Anesthesia Drugs. Various technologies such as 3d Bioprinting, Cryo-Em, Next generation Proteomics, Cloud computing, wearable sensors and IoT are used in the development of anesthetic drugs. Furthermore, rise in chronic pain cases also requires the use of anesthesia in some cases. Almost 50 million US people suffer from chronic pain and almost 17 million people suffer from high impact chronic pain. Such high number also results in demand for anesthesia drugs.

The US anesthesia drug market comprises pharmaceutical companies, medical device manufacturers, healthcare providers, and regulatory bodies. It involves the production, distribution, and administration of drugs used to induce anesthesia during medical procedures. Key players include Pfizer, Baxter, and AbbVie, while hospitals, clinics, and ambulatory surgical centers form the demand side. This ecosystem is influenced by medical advancements, patient safety regulations, and market competition. The evolving landscape emphasizes research and development for safer and more effective anesthesia drugs, while ensuring compliance with FDA standards to meet the needs of healthcare professionals and patients.

US Anesthesia Drug market is equipped with many top players such as Baxter International Inc., AbbVie, Abbott Laboratories, Hospira, Pacira Biosciences Inc., Pfizer, and Endo International. The US Anesthesia Drug market players can primarily be divided into General Anesthesia Drug market players and Local Anesthesia drug market players.

Key trends by Market Segment:

By drug type: In 2022, General Anesthesia Drugs dominated the US Anesthesia Drugs Market. General Anesthesia drugs are such anesthetics which make you fully unconscious during a surgery.

The major reasons behind their dominance in the US Anesthesia Drugs market is that most of the surgeries such as cardiovascular surgeries, general surgeries, cancer surgeries, surgeries involving hip and knee replacements require the use of General Anesthesia.

When most of the surgeries require the patient to be completely unconscious, the demand for general anesthesia drugs rises which ultimately results in general anesthesia drugs being the dominant segment in the US Anesthesia Drugs market.

By Application: In 2022, General Surgery dominated the US Anesthesia Drug market. General surgery is a broad segment of all types of surgeries which involves doing any surgical procedure anywhere in the body.

The main reason behind the dominance of General surgeries in the United States is that most of the surgeries (except dental, cosmetic and plastic surgery) come under the category of General Surgery.

Some of the surgeries that come under the category of General surgery are Breast surgery, Cardio-thoracic surgery, Color-ectal surgery, Endocrine surgery, Laparoscopic surgery, Onco surgery, Pediatric surgery, Transplant surgery and trauma surgery.

Since most of the major surgeries are a part of General Surgery segment, thus, this segment has dominance in the US Anesthesia Drug as this segment generates most of the demand for Anesthesia drugs.

By Geography: The northern region of US dominated the US Anesthesia Drug market in 2022. The major reason behind this region being the dominant segment is that this region, primarily Illinois, is home to major players of US Anesthesia Drugs companies as well as many top hospitals.

Major anesthesia drugs companies such as Baxter International, Hospira, AbbVie, Abbott Laboratories are situated in the northern region of the United States, primarily in the Illinois.

Moreover, there are also many top-notch hospitals located in this area such as Mayo Clinic, Cleveland Clinic, Memorial Sloan Kettering Cancer Centre, Dana Farber Cancer Institute, Hospitals of University of Pennsylvania, Northwestern Memorial Hospital, Barns-Jewish Hospital, etc.

As more and more people come to these hospitals to get surgeries, this also helps in generating the demand for anesthesia drugs.

There is also presence of many healthcare companies in the northern US. There are approximately 9000 healthcare companies in this region. The presence of this high number of companies also helps in making this region as the dominant segment of US Anesthesia Drugs market.

Thus, due to the presence of major anesthesia companies, hospitals, and healthcare companies, this segment happens to be the

Competitive Landscape:

The United States Anesthesia Drugs market is equipped with many well-established players making all type of Anesthesia drugs primarily Local Anesthesia drugs and General Anesthesia drugs.

Some of the well-known overall anesthesia drugs makers include Baxter International Inc., AbbVie, Abbott Laboratories, Hospira, Pacira Biosciences Inc., Pfizer, and Endo International.

These companies vie for market share through innovation, product efficacy, and pricing strategies. The landscape is dynamic, with a focus on developing advanced anesthetic agents with fewer side effects and quicker recovery times. The ongoing pursuit of superior formulations, coupled with stringent regulatory oversight by the FDA, shapes a competitive environment centered on providing safe, efficient, and cost-effective anesthesia solutions for healthcare providers and patient.

Recent Developments:

In 2020, Propofol Injectable Emulsion was launched in the US by Hikma Pharmaceuticals USA Inc.

In 2020, AbbVie was involved in the acquisition of Allergan with the aim of expanding their product mix in the fields of anesthesia, oncology and neurosciences.

In 2022, FDA gave pre-market approval to GE healthcare regarding the delivery of general anesthesia with the help of their End-Tidal Control Software.

In 2022, Harrow along with Sintetica received FDA approval for their chloroprocaine hydrochloride ophthalmic gel known as IHEEZO.

Future Outlook:

The US Anesthesia Drug Market is expected to grow at a CAGR of ~4% between the time period 2022-2028 owing to rise in ageing population, rise in surgical procedures, technological advancements, and rise in chronic pain patients.

The ageing population have been constantly rising in the United States over the years. There were around 25 people per 100 people in US in 1980s. This number became almost 55 people per 100. This number is further expected to reach 70 people per 100 by 2030. Since ageing people require more surgeries than normal people, this segment will continue to contribute to the growth of US Anesthesia Drugs market.

There has also been rise in surgical procedures in the United States. Every year, US almost sees 6 million surgical procedures. This number is further going to increase considering the rising ageing population and cancer cases. The rising surgical procedures results in the rise in the usage of anesthesia which ultimately results in the growth of US Anesthesia Drugs market.

Technology is constantly evolving and it will continue to do so in the future. Right now, there are various technological advancements in the field of anesthesiology such as 3d Bioprinting, Cryo-Em, Next generation Proteomics, Cloud computing, wearable sensors and IoT which make the work easier, faster and effective which helps in accelerating the US Anesthesia Drug market.

Anesthesia drugs are also used in the treatment of chronic pain. Chronic pain cases are on the rise in the United States. Almost 17 million people in the US suffer from chronic pain. This number is further going to rise in the future which will result in an increased demand for anesthesia thereby fueling the US Anesthesia Drug market.

 

Additional benefits of purchasing an enterprise license:

• TAM/SAM/SOM Analysis
• Customer Cohort Analysis
• Marketing Initiatives
• White Space Opportunity Analysis
• Interactive Data Visualizations
• Customization: 20 Analyst Hours
• 3 Months Post Sales Analyst Support
• Complimentary Update Next Year
• Custom Webinars